Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). (Q41250426)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). |
scientific article |
Statements
1 reference
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). (English)
1 reference
Ritsuko Komaki
1 reference
Andrew B Lassman
1 reference
Stephanie L Pugh
1 reference
Mark R Gilbert
1 reference
Kenneth D Aldape
1 reference
Sandrine Geinoz
1 reference
Jan H Beumer
1 reference
Susan M Christner
1 reference
Rakesh Gaur
1 reference
Emad Youssef
1 reference
Henry Wagner
1 reference
Minhee Won
1 reference
10 March 2015
1 reference
1 reference
17
1 reference
7
1 reference
992-998
1 reference
Identifiers
1 reference
1 reference
1 reference